Antisense RNA Down-Regulation of bcl-2 Expression in DU145 Prostate Cancer Cells Does Not Diminish the Cytostatic Effects of G3139 (Oblimersen)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (37)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
2001 • 9,275 citations
BCL-2 family members and the mitochondria in apoptosis
1999 • 3,657 citations
RNA interference is mediated by 21- and 22-nucleotide RNAs
2001 • 3,271 citations
RNAi
2000 • 2,596 citations
Gene silencing in mammals by small interfering RNAs
2002 • 1,403 citations
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
1993 • 898 citations
Bcl‐2 family: Life‐or‐death switch
2000 • 665 citations
Methods of Detection of Vascular Reactive Species
2001 • 547 citations
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
1998 • 496 citations
Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production.
1993 • 488 citations
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
2000 • 487 citations
Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
1995 • 422 citations
Bcl-2 family proteins and mitochondria
1998 • 374 citations
BCL-2: Prevention of Apoptosis as a Mechanism of Drug Resistance
1995 • 323 citations
Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis.
1993 • 275 citations
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways.
1993 • 238 citations
bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair.
1993 • 218 citations
Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene Expression
1994 • 190 citations
Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells
2000 • 180 citations
Gene Silencing Mediated by Small Interfering RNAs in Mammalian Cells
2003 • 161 citations
RNA-mediated gene silencing
2003 • 136 citations
RNAi: gene-silencing in therapeutic intervention
2002 • 134 citations
High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
1994 • 128 citations
Targeting bcl-2 gene to delay androgen-independent progression and enhance chemosensitivity in prostate cancer using antisense bcl-2 oligodeoxynucleotides
1999 • 102 citations
Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides
2002 • 90 citations
Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer
1997 • 86 citations
Inhibition of Potentially Anti-Apoptotic Proteins by Antisense Protein Kinase C-α (Isis 3521) and Antisense bcl-2 (G3139) Phosphorothioate Oligodeoxynucleotides: Relationship to the Decreased Viability of T24 Bladder and PC3 Prostate Cancer Cells
2001 • 61 citations
G3139 (oblimersen) may inhibit prostate cancer cell growth in a partially bis-CpG-dependent non-antisense manner.
2003 • 47 citations
A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells
1999 • 47 citations
Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.
1997 • 45 citations
Antisense Bcl‐2 Retrovirus Vector Increases the Sensitivity of a Human Gastric Adenocarcinoma Cell Line to Photodynamic Therapy
1999 • 45 citations
Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
2002 • 40 citations
Caspase involved synergistic cytotoxicity of bcl-2 antisense oligonucleotides and Adriamycin on transitional cell cancer cells
2000 • 35 citations
Bcl-2 regulates chondrocyte morphology and aggrecan gene expression independent of caspase activation and full apoptosis
1999 • 34 citations
The Long and Short of siRNAs
2002 • 30 citations
Changes in Gene Expression Induced by Phosphorothioate Oligodeoxynucleotides (Including G3139) in PC3 Prostate Carcinoma Cells Are Recapitulated at Least in Part by Treatment with Interferon-β and -γ
2004 • 28 citations
Growth inhibition of DU-145 prostate cancer cells by a Bcl-2 antisense oligonucleotide is enhanced by N-(2-hydroxyphenyl)all-trans retinamide
1998 • 24 citations
Cited By (0)
No citing papers found in database